• Condividi su Facebook

Medicine innovative: a gennaio nuovi bandi europei per progetti di ricerca

  • 45993
  • VARIE - UE 14/10/2019
  • BANDO - PREINFORMAZIONE

Innovative medicines initiativeL'Iniziativa Tecnologica Congiunta denominata Innovative Medicines Initiative ha pubblicato maggiori anticipazioni sui futuri bandi per progetti di ricerca dedicati alle medicine innovative.

In particolare, l'apertura del prossimo bando (IMI2 - Call 20) è prevista per il 21 gennaio 2020 e dovrebbe comprendere i seguenti topic:


L'apertura della successiva call for proposals è invece prevista per il 23 giugno 2020 e la JTI Innovative Medicines Initiative sta discuttendo se includere o meno i seguenti topic:

Neurodegeneration and other neuroscience priorities

  • Rare neurodegenerative and neurocognitive diseases clinical platform development
  • Complement in neurodegenerative diseases

Pain portfolio

  • Digital endpoints and placebo effect in chronic pain

Infection control including vaccines

  • Development of innovative personalized diagnostics and patient-guided therapies for the management of sepsis-induced immune suppression
  • Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance

Big data, digital health, clinical trials and regulatory research

  • Data lakes
  • Personalised endpoints
  • Returning clinical trial data to patients: The proactive return of clinically relevant information to study participants during and after a clinical trial

Oncology

  • Microbiome

Translational safety

  • Pharmacodynamic drug-drug interaction predictive testing by learning algorithms to enhance safety
  • Digital vivarium

Facilitating rare disease therapies (including Advanced Therapy Medical Products) reaching patients in Europe

  • Clinical outcomes assessments for rare diseases
  • Defragmenting and shortening the path to rare disease diagnosis by using genetic screening and digital technologies
Link
Quadro di finanziamento
  • H2020-JTI-IMI2 : Iniziativa Tecnologica Congiunta (JTI) denominata Medicine Innovative 2 (IMI 2) nell'ambito di Horizon 2020, il Programma Quadro di Ricerca e Innovazione dell’Unione europea
Area di interesse
  • Unione Europea